Summary
Vir Biotechnology, Inc.
Founded in 2008
Description
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Strengths
- Vir Biotechnology, Inc. has a strong market share in their industry
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Vir Biotechnology, Inc. was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
Annual Revenue
Vir Biotechnology, Inc.'s annual revenue
$427211000
Based on Kona Equity data
-
Revenue per employee
$741686
-
Variance of revenue growth
0.08
-
Annual revenue growth since founding
$1348500
-
Revenue growth rate from first known quarter to current
-55.0%
Employee Count
576 employees
-
Employee growth rate from first known quarter to current
154.4%
Executives
Minnie Kuo
Vice President, Translational & Clinical Development Operations
m**@vir.bioErik Mogalian
Vice President, Clinical Pharmacology
e**@vir.bioKaila Caprio
Manager, Clinical Operations
k**@vir.bioDouglas Stoss
Vice President, Policy & Government Affairs
d**@vir.bioChad Garner
Vice President, Product & Respiratory Executive
c**@vir.bioAlan Korman
Senior Vice President, Human Immunology
a**@vir.bioJamieson Sheffield
Market Analysis and Strategy
j**@vir.bioAnna Zumsteg
Director, Microbiology
a**@vir.bioSimon Bélanger
Scientist I, Immunology
s**@vir.bioBrian Doehle
Vice President, Biomarkers
b**@vir.bioCarey Hwang
Head Senior VP, Clinical Research, Chronic Infection
c**@vir.bioTodd Fralich
Vice President, Medical Affairs
t**@vir.bioMiaoge Xue
Scientist
m**@vir.bioVeronica Gutierrez
Administrative Assistant
v**@vir.bioPhillip Pang
Chief Medical Officer
p**@vir.bioEdward Fitzgerald
Law Lead Senior Director, Healthcare
e**@vir.bioMartin Montiel-Ruiz
Scientist I
m**@vir.bioPaul Levy
Senior Director, Transactional Attorney
p**@vir.bioChristy Hebner
Senior Vice President and Chief Operating Officer of Research, Vir Biotechnology
c**@vir.bioAlex Bangs
Chief Information Officer
a**@vir.bioLori Houle
Vice President, Quality
l**@vir.bioAine Hanly
Chief Technology Officer
a**@vir.bioCara Pilowa
Associate Director, Clinical Operations
c**@vir.bioSacha Satram
Director, Health Economics & Outcomes Research
s**@vir.bioLisa Purcell
Senior Vice President Microbiology and Virology
l**@vir.bioPauline Mak
Vice President, Corporate Controller
p**@vir.bioHeather Armstrong
Vice President, Investor Relations
h**@vir.bioSeungmin Hwang
Vice President, Genetics and HDT
s**@vir.bioChin Tay
Vice President (Nonclinical Development & Translational Research)
c**@vir.bioG Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
444 K
-
Page views per visitor
3.3
-
Daily time
6:18
-
Bounce Rate
35.6 %
Location
Unlock unlimited leads
Similar Companies
Dynavax Technologies Corporation
dynavax.com- Location: Emeryville, CA
- Annual Revenue: $459.4M
- Employees: 351
- Dynavax Technologies is focused on leveraging the power of the bodys innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
Biohaven Pharmaceutical Holding Company Ltd.
biohavenpharma.com- Founded in 2013
- Location: New Haven, CT
- Annual Revenue: $68.2M
- Employees: 202
- Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company focused on the identification and development of clinical stage compounds targeting orphan neurologic indications and other neurological pathways.
NGM Bio
ngmbio.com- Founded in 2008
- Location: South San Francisco, CA
- Annual Revenue: $77.3M
- Employees: 225
- NGM Bio is a biopharmaceutical company that is focused on harnessing powerful human biology to develop transformative therapeutics for patients. They have a broad and diverse pipeline of novel medicines that target a range of therapeutic areas and dise...
BridgeBio
bridgebio.com- Founded in 2015
- Location: Palo Alto, CA
- Annual Revenue: $70.9M
- Employees: 392
- BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. Our mission is to discover, create, test, and deliver transformative medicines to treat patients with gen...
Dendreon Pharmaceuticals LLC
dendreon.com- Founded in 1995
- Location: Seal Beach, CA
- Annual Revenue: $255.7M
- Employees: 764
- Dendreon is a commercial stage biopharmaceutical company and pioneer in the development of immunotherapy. The company's flagship product, PROVENGE (sipuleucel T), is an autologous cellular immunotherapy for the treatment of prostate cancer. Dendreon's ...
Atara Bio
atarabio.com- Founded in 2012
- Location: South San Francisco, CA
- Annual Revenue: $70.9M
- Employees: 334
- Atara Biotherapeutics is a leading off the shelf, allogeneic T cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Atara Biotherapeutics develops next gen CART therapies & off the shelf allog...
Key Information
- Name: Vir Biotechnology, Inc.
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 28; 283
- NAICS: 32541; 5417
See similar companies
-
By City San Francisco Small Biotechnology Company in San Francisco Mid-size Biotechnology Company in San Francisco Biotechnology in San Francisco Small Biotechnology in San Francisco Mid-size Biotechnology in San Francisco
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 5 Founded in 2008 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 5417 #Drug Manufacturing & Research #Medical Testing & Clinical Laboratories #Pharmaceuticals #Healthcare
Frequently Asked Questions
Vir Biotechnology, Inc.'s headquarters are located at 499 Illinois Street, Suite 500 San Francisco, CA 94158.
Vir Biotechnology, Inc.'s official website is vir.bio
Vir Biotechnology, Inc.'s annual revenue is $427.2 M.
Vir Biotechnology, Inc.'s SIC: 28; 283
Vir Biotechnology, Inc.'s NAICS: 32541; 5417.
Vir Biotechnology, Inc. has 576 employees
Vir Biotechnology, Inc. is in the industry of Biotechnology.
